ServiceUpdated on 12 September 2025

Sustained release of proteins & biologicals

About

InnoCore Pharmaceuticals is the leading drug delivery development provider of long-acting injectable dosage forms of peptides and complex biologics based on its proprietary, best-in-class polymeric drug delivery platform, SynBiosys®.

SynBiosys® can overcome the significant technical challenges of translating complex and fragile APIs into stable, tunable and scalable LAI drug products whilst maintaining the essential bioactive characteristics of the API, from peptides and biologics, to oligonucleotides or antibody drug conjugates (ADC).

Type

  • Development

Applies to

  • Biotech and Lifescience

Organisation

InnoCore Pharmaceuticals

Company (SME/startup) / 中小企業・スタートアップ

Groningen, Netherlands

Similar opportunities